Cargando…

Pan-cancer analysis of the immune aspects and prognostic value of NCAPG2

NCAPG2 has been reported to be associated with tumorigenesis in various types of cancer. However, data on the pathological mechanisms of NCAPG2 in pan-cancers remain lacking. Therefore, the study aimed to comprehensively elucidate the immune characteristics and prognostic of NCAPG2 in tumor microenv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Huidong, Chen, Ning, Li, Huanhuan, Zheng, Zhiwu, Li, Hua, Quan, Haiyan, Jin, Xing, Jiang, Ping, Wu, Qiong, Yang, Xuejiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368848/ https://www.ncbi.nlm.nih.gov/pubmed/37501987 http://dx.doi.org/10.1016/j.heliyon.2023.e18051

Ejemplares similares

NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation
por: Wang, Qi, et al.
Publicado: (2023)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma
por: Zheng, Guangrong, et al.
Publicado: (2022)

PLAG1 and NCAPG‐LCORL in livestock
por: Takasuga, Akiko
Publicado: (2016)

NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis
por: Lin, Jie, et al.
Publicado: (2023)

NCAPG Dynamically Coordinates the Myogenesis of Fetal Bovine Tissue by Adjusting Chromatin Accessibility
por: Hu, Xin, et al.
Publicado: (2020)

Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer
por: Zhang, Jingwei, et al.
Publicado: (2022)

Aberrant Expression of NCAPG is Associated with Prognosis and Progression of Gastric Cancer
por: Sun, Ding-Ping, et al.
Publicado: (2020)

NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma
por: Jiang, Shiyao, et al.
Publicado: (2022)

Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer
por: Huang, Da, et al.
Publicado: (2022)

Characterizing the Crosstalk of NCAPG with Tumor Microenvironment and Tumor Stemness in Stomach Adenocarcinoma
por: Xiang, Zheng, et al.
Publicado: (2022)

NCAPG Promotes the Proliferation of Renal Clear Cell Carcinoma via Mediating with CDK1
por: Li, Huibing, et al.
Publicado: (2022)

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022)

NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression
por: Sun, Huanhuan, et al.
Publicado: (2022)

NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
por: Xiao, Cuicui, et al.
Publicado: (2020)

Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer
por: Lin, Fei, et al.
Publicado: (2022)

Correction: NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression
por: Sun, Huanhuan, et al.
Publicado: (2022)

Prognostic significance of the pretreatment pan-immune-inflammation value in cancer patients: an updated meta-analysis of 30 studies
por: Hai-Jing, Yu, et al.
Publicado: (2023)

NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
por: Wu, Yun, et al.
Publicado: (2021)

NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN
por: Zhang, Rongguiyi, et al.
Publicado: (2022)

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer
por: Xu, Tao, et al.
Publicado: (2020)

NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis
por: Zhang, Zuwang, et al.
Publicado: (2023)

Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer
por: Zheng, Tingrui, et al.
Publicado: (2023)

Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer
por: Yang, Xiawei, et al.
Publicado: (2022)

Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer
por: Wang, Yanfeng, et al.
Publicado: (2022)

Pan-immune-inflammation value is associated with the clinical stage of colorectal cancer
por: Zhao, HanZheng, et al.
Publicado: (2022)

The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target
por: Gao, Dacheng, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis reveals the prognostic value and immunological role of SPIB
por: Ding, Meng, et al.
Publicado: (2022)

Prognostic Values of METTL3 and Its Roles in Tumor Immune Microenvironment in Pan-Cancer
por: Guo, Yang, et al.
Publicado: (2022)

Discovering the Clinical and Prognostic Role of Pan-Immune-Inflammation Values on Oral Cavity Squamous Cell Carcinoma
por: Yeh, Chia-Chi, et al.
Publicado: (2023)

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1
por: Dong, Shiqiang, et al.
Publicado: (2022)

MicroRNA‑181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG
por: Ai, Jiyuan, et al.
Publicado: (2019)

NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling
por: Gong, Chengwu, et al.
Publicado: (2019)

NCAPG is differentially expressed during longissimus muscle development and is associated with growth traits in Chinese Qinchuan beef cattle
por: Liu, Yu, et al.
Publicado: (2015)

Immunological role and prognostic value of the SKA family in pan-cancer analysis
por: Li, Zhengtian, et al.
Publicado: (2023)

Prognostic value of pan-immune-inflammation value in colorectal cancer patients: A systematic review and meta-analysis
por: Yang, Xiao-Chuan, et al.
Publicado: (2022)

Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
por: He, Kangwei, et al.
Publicado: (2022)

Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
por: Shen, Liping, et al.
Publicado: (2023)

Pan-Cancer Analysis of Prognostic and Immune Infiltrates for CXCs
por: Li, Long, et al.
Publicado: (2021)

ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma
por: Zhang, Qiaoling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h6lacun3dlclpfeoovcuc4mt0n